| Bioactivity | 4-Nitroso hydrochlorothiazide-13C,15N2,d2 is the deuterium, 13C-, and 15-labeled 4-Nitroso hydrochlorothiazide[1]. | ||||||||||||
| Invitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[7]. | ||||||||||||
| Name | 4-Nitroso hydrochlorothiazide-13C,15N2,d2 | ||||||||||||
| Formula | C613CH5D2ClN215N2O5S2 | ||||||||||||
| Molar Mass | 331.73 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. |
4-Nitroso hydrochlorothiazide-13C,15N2,d2
CAS: F: C613CH5D2ClN215N2O5S2 W: 331.73
4-Nitroso hydrochlorothiazide-13C,15N2,d2 is the deuterium, 13C-, and 15-labeled 4-Nitroso hydrochlorothiazide.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.